CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors https://www.biorxiv.org/content/10.1101/2023.02.02.526674v1?med=mas
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors https://www.biorxiv.org/content/10.1101/2023.02.02.526674v1?med=mas